Health systems are rapidly embedding generative AI into workflows—summarizing visits, prioritizing imaging, aiding documentation and clinical decision support—but CIOs warn a distinct enterprise risk has emerged: hallucinations. Unlike conventional software bugs, generative models can produce fluent, authoritative outputs that are factually wrong, raising patient safety, liability and workflow integrity concerns. Recent deployments revealed errors in summaries, misprioritized studies and faulty recommendations that could mislead clinicians if unchecked.
CIOs and clinical leaders are responding by strengthening governance: instituting model validation, clinical testing, provenance tracking, monitoring and vendor accountability, and by embedding human review and escalation paths. Strategies include standardized safety testing, audit trails, data lineage, role-based access, and post-deployment surveillance to detect drift and hallucination patterns. Experts urge formal policies that balance innovation and risk, investment in clinician training and cross-disciplinary review, and engagement with regulators to clarify standards — measures intended to preserve trust while harnessing AI’s operational benefits.
